Battery X Metals Presents Positive Preliminary Rebalancing Trial Results and Accelerated Commercialization Progress
Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing
Trial Results Demonstrating Significant Estimated Driving Range Improvements
and Accelerated Commercialization Progress of Its Patent-Pending Lithium-Ion
Battery Rebalancing Technology Platform
News Release Highlights:
1. Battery X Metals' patent-pending lithium-ion battery rebalancing platform has demonstrated
positive preliminary estimated driving range improvements of up to approximately 255 kilometres
across real-world electric vehicle performance trials, supporting meaningful battery capacity
recovery, advanced diagnostics, sustained performance recovery, and validation across multiple
commercial and passenger EV platforms.
2. The Company has strengthened its intellectual property portfolio through the completion of its
International Patent Cooperation Treaty (PCT) patent application, preserving priority rights while
establishing a pathway to pursue patent protection in more than 150 countries. Concurrently,
Battery X Metals has completed or is actively advancing compatibility development across five
strategic electric vehicle platforms, including the Nissan Leaf, Tesla Model 3 and Model Y, Hyundai
Ioniq, Chevrolet Volt, and the VMC 1200 electric truck.
3. Battery X Metals is accelerating commercialization through the advancement of an integrated EV
battery diagnostics platform utilizing an onboard diagnostics (OBD-II) interface, together with the
continued development of its Rebalancing Machine hardware and software ecosystem, including
wireless connectivity, standardized battery health reporting, commercial hardware refinements,
and UL certification initiatives, positioning its patent-pending lithium-ion battery rebalancing
technology platform for broader commercial deployment as millions of electric vehicles are expected
to transition beyond their original battery warranty coverage.
VANCOUVER, British Columbia – July 10, 2026 – Battery X Metals Inc. (CSE:BATX) (OTCQB:BATXF)
(FSE:5YW0, WKN:A41RJF) (“ Battery X Metals ” or the “ Company”) an energy transition resource
exploration and technology company, announces a comprehensive commercialization update for its
patent-pending lithium-ion battery rebalancing technology platform, highlighting preliminary
performance validation achieved through a series real-world electric vehicle performance trials, together
with initiatives intended to accelerate commercialization and broader market deployment.
Over the past twelve months, Battery X Metals has systematically advanced the development and
validation of its patent-pending lithium-ion battery rebalancing technology platform through a series of
real-world vehicle performance trials and multi-platform evaluations. What began as validation of the
Company's core battery rebalancing technology has progressively expanded to demonstrate integrated
battery diagnostics, targeted corrective intervention, sustained long-term performance recovery, and
applicability across multiple electric vehicle platforms.
Collectively, these preliminary validation milestones have established an important technical foundation
supporting the Company's transition from technology validation toward commercialization. As electric
vehicle adoption continues to accelerate globally and an increasing number of vehicles begin to exit
original battery warranty coverage, Battery X Metals believes demand for technologies capable of
extending battery lifespan, restoring usable battery capacity and reducing total cost of ownership will
continue to grow.
Accordingly, the Company is now advancing the next phase of development by accelerating
commercialization initiatives intended to support manufacturing readiness, expand vehicle compatibility,
strengthen strategic industry relationships and position the Rebalancing Machine for broader commercial
deployment.
In parallel with these technical and commercialization advancements, and as previously disclosed in the
Company's news release dated April 21, 2026, the Company completed a significant intellectual property
milestone through the filing of an International patent application under the Patent Cooperation Treaty
("PCT"). The PCT application preserves priority rights from the Company's previously filed U.S. provisional
patent applications with the United States Patent and Trademark Office (USPTO) while establishing a
pathway to pursue patent protection in more than 150 countries. The Company believes this milestone
enhances the long-term defensibility of its proprietary technology platform and provides an important
foundation to support future commercialization, licensing opportunities, strategic partnerships, and
international market expansion.
Performance Validation of Patent-Pending Lithium-Ion Battery Rebalancing Machine
Battery X Metals, through its wholly-owned subsidiary, Battery X Rebalancing Technologies Inc., has
developed a next-generation, patent-pending lithium-ion battery rebalancing platform (the "Rebalancing
Machine") designed to restore usable battery capacity lost through naturally occurring lithium-ion cell
imbalance, extend the remaining useful life of electric vehicle ("EV") battery packs, and reduce the need
for premature battery replacement. Through a series of real-world performance trials, the Rebalancing
Machine has demonstrated measurable improvements in battery capacity utilization, driving range,
diagnostic capability, and long-term performance retention across multiple EV platforms, supporting the
Company's commercialization strategy.
As disclosed in the Company's news releases dated July 4, July 25 and October 24, 2025, and January 13
and May 22, 2026, the Company completed a series of real-world driving performance trials (each, a
"Trial," and collectively, the "Trials") and, in the case of the May 22, 2026 news release, reported the
results of lithium-ion battery rebalancing trials conducted by multiple international arm's-length third-
party automotive service centres utilizing the Company's patent-pending Rebalancing Machine.
Collectively, these Trials evaluated the Rebalancing Machine across progressively broader operating
conditions, battery chemistries and electric vehicle platforms.
The initial two Trials evaluated the Rebalancing Machine on severely degraded Class 3 commercial electric
vehicles (each, an “Electric Truck”) exhibiting significant battery capacity loss resulting from naturally
occurring lithium-ion cell imbalance. As disclosed in the Company's July 4, 2025 news release, the first
Trial demonstrated the Rebalancing Machine's ability to restore a severely degraded battery pack from a
reported estimated driving range of approximately 40 kilometres to an estimated 295 kilometres under
no-load conditions following completion of a full battery rebalancing procedure, representing an increase
of approximately 255 kilometres, or approximately 637%. Importantly, the restored estimated driving
range closely approximated the manufacturer's reported operating range for the platform, demonstrating
the technology's ability to recover substantial usable battery capacity without requiring battery pack
replacement while supporting a lower-cost battery recovery solution for commercial fleet operators.
As disclosed in the Company's July 25, 2025 news release, the second Trial expanded validation by
demonstrating the Rebalancing Machine's integrated battery diagnostic capabilities. During the
evaluation, the Rebalancing Machine identified a defective battery cell exhibiting abnormal self-discharge
within a parallel-connected cell group that had caused premature vehicle shutdown below approximately
60% state of charge ("SOC"). Following targeted replacement of the affected cell group and completion
of a battery rebalancing procedure, the Electric Truck's effective driving range increased from
approximately 40 kilometres to an estimated 265 kilometres under no-load conditions, representing an
increase of approximately 225 kilometres, or approximately 563%. Beyond the recovery in driving range,
the Trial demonstrated the Rebalancing Machine's ability to combine advanced battery diagnostics with
targeted corrective intervention, supporting the potential for selective battery repair strategies as an
alternative to complete battery pack replacement where appropriate.
As disclosed in the Company's October 24, 2025 news release, the Company subsequently completed a
follow-up validation assessment of the second Electric Truck to evaluate the durability of the performance
improvements observed during the July 2025 Trial. Following approximately four months and more than
2,000 kilometres of continued real-world operation, the vehicle maintained stable range performance,
achieving an estimated driving range of approximately 250 kilometres under comparable testing
conditions and a weighted average effective driving range of approximately 220 kilometres per full charge
over approximately 92% cumulative state of charge utilization. These results demonstrated that the
battery performance improvements achieved through the targeted intervention and rebalancing
procedure were substantially maintained over time, supporting the Rebalancing Machine's potential to
deliver sustained battery performance recovery and extend the remaining useful life of commercial EV
battery packs.
As disclosed in the Company's January 13, 2026 news release, the Company further expanded validation
through a real-world performance trial on a light-duty electric vehicle equipped with a severely
imbalanced 144-cell lithium nickel manganese cobalt oxide (NMC) battery pack that had become
effectively inoperable, exhibiting an estimated pre-rebalancing driving range of approximately 0.1
kilometres per charge. Following completion of a full battery rebalancing procedure, the vehicle achieved
an average estimated driving range of approximately 135.9 kilometres per charge under mixed driving
conditions. The rebalancing process also materially reduced cell-level voltage variance across the battery
pack, demonstrating improved battery pack balance, enhanced utilization of existing battery capacity, and
the ability to restore meaningful vehicle operability without replacing battery cells.
Further, as disclosed in the Company's May 22, 2026 news release, the Company announced the results
of a series of lithium-ion battery rebalancing trials conducted by multiple international arm's-length third-
party automotive service centres on multiple electric vehicle platforms manufactured by BYD Company
Limited ("BYD") utilizing the Company's next-generation, patent-pending Rebalancing Machine. The
evaluations demonstrated estimated driving range improvements of up to approximately 84 kilometres
per charge across BYD Song, Seal and Han vehicle platforms, supporting the repeatability of the
Rebalancing Machine across multiple high-volume EV platforms and further demonstrating its commercial
applicability within one of the world's largest electric vehicle ecosystems.
Collectively, these preliminary validation activities demonstrate the Rebalancing Machine's ability to
restore usable battery capacity lost through naturally occurring lithium-ion cell imbalance, integrate
advanced battery diagnostics to identify cell-level defects requiring targeted corrective intervention,
sustain recovered battery performance under continued real-world operation, and deliver measurable
performance improvements across multiple electric vehicle platforms and battery configurations.
The Company believes these preliminary validation milestones establish an important technical
foundation supporting the continued commercialization of its patent-pending lithium-ion battery
rebalancing technology platform across an expanding range of electric vehicle platforms and operating
environments, as the global population of out-of-warranty electric vehicles is anticipated to grow and
demand is anticipated to increase for battery lifespan extension solutions that reduce total cost of
ownership.
Platform Expansion Supporting Commercialization Initiatives
A foundational component of the Company's commercialization strategy is the systematic expansion of
the Rebalancing Machine's compatibility across high-volume electric vehicle battery platforms. Through
its ongoing research and development program, Battery X Metals continues to advance the engineering
of proprietary battery adaptors and connector solutions designed to enable the Rebalancing Machine to
physically interface with an expanding range of lithium-ion battery architectures commonly found in out-
of-warranty electric vehicles. The Company believes this platform-by-platform compatibility strategy is
fundamental to supporting broad commercial deployment of its patent-pending lithium-ion battery
rebalancing technology.
The Company announces that it has successfully completed development of a proprietary battery adaptor
providing compatibility across all North American Nissan Leaf battery configurations. The Nissan Leaf was
among the world's earliest mass-market battery electric vehicles and remains one of the largest
populations of aging battery electric vehicles in North America. Since its launch in December 2010, more
than 650,000 Nissan Leaf vehicles have been sold globally,1 including 114,808 vehicles sold in the United
States between 2010 and 2017, where it ranked as the second best-selling plug-in electric vehicle during
that period.2 As these vehicles continue transitioning beyond their original battery warranty coverage, the
Company believes they represent a substantial and growing addressable market for battery diagnostics,
rebalancing and battery lifespan-extension solutions, and that compatibility with the Nissan Leaf platform
represents an important commercialization milestone supporting future deployment into the growing
battery lifecycle extension market.
The Company further announces that it has commenced adaptor engineering initiatives targeting the
Hyundai Ioniq and Chevrolet Volt battery platforms. As part of these initiatives, the Company's technical
team completed detailed battery interface measurements and dimensional characterization of both
battery systems. The resulting engineering data has been provided to the Company's strategic
development partner, Beijing Pengneng Science & Technology Ltd., to support the design and engineering
of proprietary adaptor and connector solutions intended to enable compatibility with the Rebalancing
Machine.
The Hyundai Ioniq and Chevrolet Volt represent strategically important electrified vehicle platforms within
the North American market. The Chevrolet Volt was among the earliest high-volume plug-in electric
vehicles, achieving cumulative global sales of approximately 178,785 vehicles prior to its discontinuation,
with approximately 150,049 vehicles (approximately 84%) sold in the United States.3 This substantial U.S.
vehicle population represents an attractive addressable market as these vehicles continue to age beyond
their original battery warranty periods. The original Hyundai IONIQ achieved significant adoption across
the United States, Canada and Europe, with approximately 251,742 vehicles sold across these markets
through 2022, including approximately 82,264 vehicles in the United States, 16,531 vehicles in Canada
and 152,947 vehicles in Europe. The United States represented approximately 32.7% of reported IONIQ
sales across these three markets.4 As these vehicle populations continue to age beyond their original
battery warranty periods, the Company believes they represent attractive platforms for future battery
diagnostics, rebalancing and battery lifespan-extension services.
These initiatives build upon the Company's previously announced compatibility development activities
targeting the Tesla Model 3 battery platform. As disclosed in the Company's news release dated January
2, 2026, the Company completed a high-resolution three-dimensional (3D) scan of a Tesla Model 3 battery
pack, establishing the foundational digital reference required to engineer proprietary adaptor and
connector solutions. Tesla accounted for approximately 45% of U.S. electric vehicle sales in 2024,5 while
cumulative Tesla Model 3 sales reached an estimated 2.63 million vehicles globally by the end of the third
quarter of 2024.6 As these vehicles continue to age, a growing proportion is expected to transition beyond
their original battery warranty coverage, increasing the addressable market for battery diagnostics,
rebalancing and battery lifespan extension technologies.
In addition to these consumer vehicle platforms, the Company has completed development of a
proprietary battery adaptor for the VMC 1200 Class 3 commercial electric truck platform. This
compatibility supported the Company's previously disclosed commercial vehicle validation activities and
further demonstrates the applicability of the Rebalancing Machine across both commercial fleet and
passenger electric vehicle battery platforms.
Collectively, these initiatives reflect a deliberate, platform-by-platform commercialization strategy
designed to systematically expand the addressable market for the Rebalancing Machine across both
commercial fleet and consumer electric vehicle markets.
Current Platform Compatibility Roadmap
Electric Vehicle Platform Development Status
Nissan Leaf Adaptor development completed
VMC 1200 Adaptor development completed
Tesla Model 3 and Model Y Adaptor engineering underway
Hyundai Ioniq Adaptor engineering underway
Chevrolet Volt Adaptor engineering underway
By progressively expanding compatibility across high-volume electric vehicle battery architectures, the
Company believes it is establishing the technical foundation necessary to support broader commercial
deployment of its patent-pending lithium-ion battery rebalancing technology platform. As additional
vehicle platforms are incorporated into the Rebalancing Machine ecosystem, the Company believes it will
continue to expand the addressable market for its battery diagnostics, rebalancing and battery lifespan
extension solutions.
Accelerated Commercialization Initiatives
Building upon the preliminary validation milestones described herein, the Company is advancing a series
of commercialization initiatives intended to strengthen its product offering, support commercial
readiness, and establish the operational framework necessary for broader market deployment of its
patent-pending lithium-ion battery rebalancing technology platform.
Battery Diagnostics as the Front End of the Battery Lifecycle Ecosystem
As part of its broader commercialization strategy, the Company has been evaluating the integration of an
advanced EV battery diagnostics platform utilizing an onboard diagnostics (OBD-II) interface, together
with a complementary hardware-enabled software platform intended to support battery health
assessment and reporting. The Company believes battery diagnostics represent a critical first step in the
battery rebalancing process, providing the information necessary to determine whether battery
performance degradation may be attributable to lithium-ion cell imbalance prior to recommending
corrective intervention.
Through communication with a vehicle's battery management system (BMS), the contemplated
diagnostics platform is expected to retrieve and analyze key battery health parameters, including state of
health, cell voltages, cell temperature, and other operational metrics relevant to battery condition. These
diagnostic outputs are intended to provide automotive service providers with standardized battery health
assessments that may assist in identifying battery packs exhibiting characteristics suitable for battery
rebalancing.
The Company envisions battery diagnostics serving as the initial customer engagement point within a
broader battery lifecycle management ecosystem. Under the Company's anticipated commercial
workflow, customers would first receive a battery health assessment through participating automotive
service centres utilizing the diagnostics platform. Where battery diagnostics identify cell imbalance as a
contributing factor to battery performance degradation, the Rebalancing Machine may subsequently be
recommended as a battery recovery solution. The Company believes this complementary diagnostics and
battery rebalancing ecosystem has the potential to strengthen customer engagement, enhance service
workflows, and support utilization of its battery rebalancing technology. As part of this initiative, the
Company is evaluating opportunities to leverage established battery diagnostics technologies, software
capabilities and industry expertise to accelerate commercialization while focusing internal development
efforts on integration with its proprietary battery rebalancing platform.
Software Development and User Experience
In parallel, the Company has been evaluating the scope of work required to develop a first-generation
commercial software platform for the Rebalancing Machine and has been assessing software engineering
resources capable of supporting its implementation. The anticipated software architecture is expected to
include an intuitive operator interface and user experience, wireless connectivity supporting over-the-air
(OTA) software updates, cloud-based storage of pre- and post-rebalancing battery data, and the
automated generation of standardized battery health reports for customers.
The Company believes these software capabilities are expected to improve operational efficiency, simplify
machine operation, standardize reporting across automotive service centres, and provide customers with
comprehensive documentation of battery condition before and after battery rebalancing procedures.
Collectively, these initiatives are intended to support a more scalable and user-friendly commercial
product while enabling consistent customer reporting across future deployment locations.
Commercial Hardware Development and Product Certification
The Company has completed commercial hardware design refinements for the Rebalancing Machine,
representing an important milestone in preparing the platform for commercial deployment. These
refinements are intended to enhance manufacturability, product functionality and commercial
presentation while establishing the design foundation for a production-ready commercial unit.
As the next phase of commercialization, the Company has been evaluating the negotiation of a hardware
development agreement with its strategic development partner, to support development and production
of the next-generation commercial Rebalancing Machine. Subject to the completion of such
arrangements, available capital resources and continued commercialization progress, the Company
intends to advance the commercial unit through applicable third-party product testing and certification
processes, including Underwriters Laboratories (UL) certification, where appropriate.
The Company believes commercial hardware production and product certification represent mission-
critical steps toward commercialization, as successful completion of these activities is expected to support
broader deployment of the Rebalancing Machine within automotive service environments and other
commercial applications.
Collectively, these commercialization initiatives are intended to complement the Company's technical
validation and platform compatibility activities by expanding the functionality of its battery lifecycle
management ecosystem, improving customer and operator experience, supporting commercial
readiness, and establishing the operational foundation necessary for broader deployment of the
Company's patent-pending lithium-ion battery rebalancing technology platform.
Advancement of these initiatives remains subject to, among other things, continued product
development, the negotiation and completion of definitive commercial agreements, available capital
resources, third-party certification processes and the Company's ongoing commercialization priorities.
Transitioning Toward Commercial Execution
The milestones summarized herein reflect the continued evolution of the Company's patent-pending
lithium-ion battery rebalancing technology platform through successive stages of development, including
technology validation, integrated battery diagnostics, long-term performance verification, platform
compatibility expansion, software enhancement and product development.
Building upon these technical and operational achievements, the Company's focus is increasingly directed
toward commercial execution through continued platform compatibility expansion, manufacturing
readiness, software development, product certification, strategic commercial relationships and broader
market deployment initiatives designed to support the commercialization of the Rebalancing Machine.
While the timing and scope of commercialization activities remain subject to, among other things,
continued product development, available capital resources, strategic relationships and customary
regulatory and commercial requirements, the Company believes the progress achieved to date establishes
a meaningful foundation from which to advance the commercialization of its patent-pending lithium-ion
battery rebalancing technology platform.
As the global population of out-of-warranty electric vehicles is anticipated to grow and demand is
anticipated to increase for battery lifespan extension solutions that reduce total cost of ownership, the
Company believes these preliminary validation milestones and commercialization initiatives position it to
pursue opportunities across an expanding range of electric vehicle platforms and operating environments.
The Problem: Rising EV Adoption Presents New Battery Lifecycle Challenges
In 2024, global EV sales reached approximately 17.1 million units, representing a 25% increase from 2023.7
With cumulative global EV sales from 2015 to 2023 totaling an estimated over 40 million units, 8 a
significant share of the global EV fleet is expected to exit warranty coverage over the coming years. 9,10